Rescue in vitro maturation may increase the pregnancy outcomes among women undergoing intracytoplasmic sperm injection

Introduction To investigate whether rescue in vitro maturation (R-IVM) improves the reproductive outcomes among women undergoing intracytoplasmic sperm injection (ICSI) after one oocyte retrieved cycle. Methods Between January 2019 and December 2020, 2602 women who underwent ICSI in the Reproductive Medicine Center of Tongji Hospital, Wuhan, China, were included in our retrospective cohort study. There were 2112 women undergoing only ICSI and 490 women with R-IVM followed by ICSI. The intermediate reproductive outcomes and pregnancy outcomes were assessed, including the number of normally fertilized embryos, number of cleaved embryos, number of good-quality embryos, number of day-3 available embryos, number of embryos cultured past day-3, number of blastocysts, number of available blastocysts, biochemical pregnancy, miscarriage, clinical pregnancy and live birth. The perinatal outcomes were also assessed, including preterm birth and birth weight. The abovementioned outcomes were also calculated for in vivo matured and R-IVM oocytes separately in women undergoing ICSI with R-IVM group. Result(s) Compared with the women who underwent only ICSI, those who underwent ICSI with R-IVM had higher numbers of MII oocytes, normally fertilized embryos, cleaved embryos, day-3 available embryos, embryos cultured past day-3, and higher oocyte maturation rate, available embryo rate than women undergoing only ICSI. Additionally, we found that women undergoing ICSI with R-IVM had an increased chance of clinical pregnancy (adjusted OR=1.50, 95% CI: 1.17–1.93) and cumulative live birth (adjusted OR=1.35, 95% CI: 1.07–1.71). After propensity score matching (PSM), the cumulative live birth rate was 60.1% for women undergoing ICSI with R-IVM versus 54.9% for women undergoing only ICSI (OR=1.24, 95% CI: 0.94–1.63). The reproductive outcomes were also significantly different when calculated for in vivo matured and R-IVM oocytes separately in women undergoing ICSI with R-IVM group. All live births from R-IVM embryos were healthy and without malformations or complications. Conclusion R-IVM may improve the reproductive outcomes of women undergoing ICSI. It may also provide a reference for the safety of R-IVM. This study maybe support a routine application of R-IVM among patients who intend to undergo ICSI.

[1]  Z. Gajewski,et al.  Signaling mechanisms and their regulation during in vivo or in vitro maturation of mammalian oocytes , 2022, Reproductive Biology and Endocrinology.

[2]  R. Krisher.  Present state and future outlook for the application of in vitro oocyte maturation in human infertility treatment , 2022, Biology of Reproduction.

[3]  S. Ozturk.  Molecular determinants of the meiotic arrests in mammalian oocytes at different stages of maturation , 2022, Cell cycle.

[4]  U. Jeschke,et al.  Factors Influencing the In Vitro Maturation (IVM) of Human Oocyte , 2021, Biomedicines.

[5]  R. Chian,et al.  Chromosome aneuploidy analysis in embryos derived from in vivo and in vitro matured human oocytes , 2021, Journal of translational medicine.

[6]  O. Ishihara,et al.  International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014†. , 2021, Human reproduction.

[7]  R. Gilchrist,et al.  Approaches to oocyte meiotic arrest in vitro and impact on oocyte developmental competence , 2021, Biology of Reproduction.

[8]  E. Labarta,et al.  Does Coenzyme Q10 Supplementation Improve Human Oocyte Quality? , 2021, International journal of molecular sciences.

[9]  M. Klutstein,et al.  Age-Dependent in vitro Maturation Efficacy of Human Oocytes – Is There an Optimal Age? , 2021, Frontiers in Cell and Developmental Biology.

[10]  Yiqing Zhao,et al.  The Improvement and Clinical Application of Human Oocyte In Vitro Maturation (IVM) , 2021, Reproductive Sciences.

[11]  P. Leung,et al.  A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China , 2021, The Lancet.

[12]  E. Telfer,et al.  In vitro growth and maturation of primordial follicles and immature oocytes. , 2021, Fertility and sterility.

[13]  Qi Yu,et al.  Effect of the time interval between oocyte retrieval and ICSI on embryo development and reproductive outcomes: a systematic review , 2021, Reproductive Biology and Endocrinology.

[14]  Shiro Tanaka,et al.  Retrolaminar Block Versus Paravertebral Block for Pain Relief After Less-Invasive Lung Surgery: A Randomized, Non-Inferiority Controlled Trial , 2021, Cureus.

[15]  N. Kornilov,et al.  The live birth in a woman with resistant ovary syndrome after in vitro oocyte maturation and preimplantation genetic testing for aneuploidy , 2021, Journal of Assisted Reproduction and Genetics.

[16]  Boe,et al.  Genetic insights into biological mechanisms governing human ovarian ageing , 2021, Nature.

[17]  A. Hampl,et al.  Cytoplasmic maturation in human oocytes: an ultrastructural study † , 2020, Biology of reproduction.

[18]  OUP accepted manuscript , 2021, Human Reproduction.

[19]  Kristine Busalacchi,et al.  Dagger , 2021, Encyclopedic Dictionary of Archaeology.

[20]  T. Strowitzki,et al.  Maternal and neonatal outcome and children's development after medically assisted reproduction with in-vitro matured oocytes-a systematic review and meta-analysis. , 2020, Human reproduction update.

[21]  H. Tournaye,et al.  Expanding the time interval between ovulation triggering and oocyte injection: does it affect the embryological and clinical outcome? , 2020, Human reproduction.

[22]  In vitro maturation: a committee opinion. , 2020, Fertility and sterility.

[23]  R. Gilchrist,et al.  Metabolic co-dependence of the oocyte and cumulus cells: essential role in determining oocyte developmental competence. , 2020, Human reproduction update.

[24]  B. Mol,et al.  In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial. , 2020, Human reproduction.

[25]  M. Carvalho,et al.  The effect of denudation and injection timing in the reproductive outcomes of ICSI cycles: new insights into the risk of in vitro oocyte ageing. , 2020, Human reproduction.

[26]  M. Diamond,et al.  Luteinizing hormone-independent rise of progesterone as the physiological trigger of the ovulatory gonadotropins surge in the human. , 2020, Fertility and sterility.

[27]  Intracytoplasmic sperm injection (ICSI) for non-male factor indications: a committee opinion. , 2020, Fertility and sterility.

[28]  G. Lin,et al.  The mitochondrial DNA copy number of cumulus granulosa cells may be related to the maturity of oocyte cytoplasm. , 2020, Human reproduction.

[29]  H. Tournaye,et al.  Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome , 2020, Human reproduction open.

[30]  L. Rienzi,et al.  The effect of ICSI-related procedural timings and operators on the outcome. , 2020, Human reproduction.

[31]  T. Yoon,et al.  Obstetrical, neonatal, and long-term outcomes of children conceived from in vitro matured oocytes. , 2019, Fertility and sterility.

[32]  Z. Rosenwaks,et al.  High proportion of immature oocytes in a cohort reduces fertilization, development, pregnancy and live birth rates following ICSI. , 2019, Reproductive biomedicine online.

[33]  Marina De Vos,et al.  DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients. , 2019, Human reproduction.

[34]  R. Vassena,et al.  Altered cytoplasmic maturation in rescued in vitro matured oocytes. , 2019, Human reproduction.

[35]  B. Mol,et al.  The effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilization in women with a high antral follicle count. , 2019, Human reproduction.

[36]  A. Ben-Haroush,et al.  Morphokinetic characteristics of embryos derived from in-vitro-matured oocytes and their in-vivo-matured siblings after ovarian stimulation. , 2019, Reproductive biomedicine online.

[37]  J. Busse,et al.  Non-inferiority Randomized Controlled Trials , 2019, Evidence-Based Surgery.

[38]  A. Hampl,et al.  Egg maturity assessment prior to ICSI prevents premature fertilization of late-maturing oocytes , 2019, Journal of Assisted Reproduction and Genetics.

[39]  A. Pellicer,et al.  Do immature and mature sibling oocytes recovered from stimulated cycles have the same reproductive potential? , 2018, Reproductive biomedicine online.

[40]  R. Hart,et al.  In vitro maturation. , 2018, Best practice & research. Clinical obstetrics & gynaecology.

[41]  M. Meseguer,et al.  Let's rescue oocytes: in vitro maturation 2.0 is coming. , 2018, Fertility and sterility.

[42]  D. Geerts,et al.  Cumulative live birth rates in more than 3,000 patients with poor ovarian response: a 15-year survey of final in vitro fertilization outcome. , 2018, Fertility and sterility.

[43]  E. Anckaert,et al.  An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield , 2017, Human reproduction.

[44]  R. Chian,et al.  Development of in vitro maturation techniques for clinical applications. , 2017, Fertility and sterility.

[45]  T. Strowitzki,et al.  Two-year development of children conceived by IVM: a prospective controlled single-blinded study , 2017, Human reproduction.

[46]  Michel De Vos,et al.  The definition of IVM is clear-variations need defining. , 2016, Human reproduction.

[47]  Jie Yan,et al.  Role of Sirt3 in mitochondrial biogenesis and developmental competence of human in vitro matured oocytes. , 2016, Human reproduction.

[48]  P. Lonergan,et al.  Maturation of Oocytes in Vitro. , 2016, Annual review of animal biosciences.

[49]  Paola Viganò,et al.  The ICSI procedure from past to future: a systematic review of the more controversial aspects. , 2015, Human reproduction update.

[50]  Osamu Ishihara,et al.  International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006. , 2013, Human reproduction.

[51]  Lixia Zhu,et al.  Blastocyst culture and cryopreservation to optimize clinical outcomes of warming cycles. , 2013, Reproductive biomedicine online.

[52]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.